MicroRNA-650 expression in glioma is associated with prognosis of patients. (Q55461471)

12 July 2018

title

MicroRNA-650 expression in glioma is associated with prognosis of patients. (English)

1 reference

12 July 2018

1 reference

Boqian Sun

1

1 reference

12 July 2018

Bo Pu

2

1 reference

12 July 2018

Dake Chu

3

1 reference

12 July 2018

Xiaodan Chu

4

1 reference

12 July 2018

Wei Li

5

1 reference

12 July 2018

Dun Wei

6

1 reference

12 July 2018

publication date

24 September 2013

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

115

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

375-380

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/s11060-013-1243-y

exact match

0 references

cites work

The new WHO classification of brain tumours

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Conditional survival of high-grade glioma in Los Angeles County during the year 1990-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Towards personalized therapy for patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNA function in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNAs in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

microRNAs in colon cancer: a roadmap for discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNAs in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNAs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

MiR-27 as a prognostic marker for breast cancer progression and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1243-Y

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

12 December 2020

MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis

1 reference

12 December 2020

MicroRNAs as promising biomarkers for gastric cancer

1 reference

12 December 2020

MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas

1 reference

12 December 2020

10.1007/S11060-013-1243-Y

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018